oncology research

Dallas’ Lantern Pharma Hits Major Milestone on its AI Platform to Advance its Oncology Drug Research and Development

by | Nov 18, 2020
Lantern Pharma amassed 1 billion data points on its proprietary artificial intelligence platform, which it believes is the most of any company in biotech. Now, the company is able to reduce cost, time, and risk to establish a more sustainable route in oncology drug development.
MORE
Dr. Theodora Ross
UT Southwestern Doctor Fights Cancer With Genetics
by | Feb 9, 2016
At any given moment, thirteen million people in the United States have cancer. For each of those thirteen million, there are family members who are wondering: Is this cancer part of a pattern? Does cancer run in my family? Am I at risk?
MORE